Financials (USD)
Sales 2024 * | 117M | Sales 2025 * | 130M | Capitalization | 91.13M |
---|---|---|---|---|---|
Net income 2024 * | -11M | Net income 2025 * | 1M | EV / Sales 2024 * | 0.78 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.7 x |
P/E ratio 2024 * |
-7.99
x | P/E ratio 2025 * |
192
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.37% |
Latest transcript on Depomed Inc
Managers | Title | Age | Since |
---|---|---|---|
Heather Mason
CEO | Chief Executive Officer | 63 | 19-01-31 |
Ajay Patel
DFI | Director of Finance/CFO | 40 | 19-06-30 |
Howard Franklin
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-05 |
Members of the board | Title | Age | Since |
---|---|---|---|
Peter Staple
CHM | Chairman | 72 | 03-10-31 |
James Tyree
BRD | Director/Board Member | 71 | 16-09-30 |
William McKee
BRD | Director/Board Member | 62 | 17-02-28 |
1st Jan change | Capi. | |
---|---|---|
+33.46% | 701B | |
+26.24% | 570B | |
+0.93% | 381B | |
+21.03% | 334B | |
+17.51% | 322B | |
+0.74% | 209B | |
+2.95% | 212B | |
-6.05% | 205B | |
-3.61% | 157B |